Brain MRI findings in COVID-19 patients with PRES: A systematic review.
Clin Imaging
; 81: 107-113, 2022 Jan.
Article
in English
| MEDLINE | ID: covidwho-1525733
ABSTRACT
BACKGROUND:
Numerous case reports and case series have described brain Magnetic Resonance Imaging (MRI) findings in Coronavirus disease 2019 (COVID-19) patients with concurrent posterior reversible encephalopathy syndrome (PRES).PURPOSE:
We aim to compile and analyze brain MRI findings in patients with COVID-19 disease and PRES.METHODS:
PubMed and Embase were searched on April 5th, 2021 using the terms "COVID-19", "PRES", "SARS-CoV-2" for peer-reviewed publications describing brain MRI findings in patients 21 years of age or older with evidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and PRES.RESULTS:
Twenty manuscripts were included in the analysis, which included descriptions of 30 patients. The average age was 57 years old. Twenty-four patients (80%) required mechanical ventilation. On brain MRI examinations, 15 (50%) and 7 (23%) of patients exhibited superimposed foci of hemorrhage and restricted diffusion respectively.CONCLUSIONS:
PRES is a potential neurological complication of COVID-19 related disease. COVID-19 patients with PRES may exhibit similar to mildly greater rates of superimposed hemorrhage compared to non-COVID-19 PRES patients.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Posterior Leukoencephalopathy Syndrome
/
COVID-19
Type of study:
Reviews
/
Systematic review/Meta Analysis
Limits:
Humans
/
Middle aged
Language:
English
Journal:
Clin Imaging
Journal subject:
Diagnostic Imaging
Year:
2022
Document Type:
Article
Affiliation country:
J.clinimag.2021.10.003
Similar
MEDLINE
...
LILACS
LIS